Blog
![](https://dupuytrens.org/wp-content/uploads/2019/01/Light_1200X519-768x332.jpg)
Shine a light on Dupuytren?
Dupuytren biology has a lot of overlap with wound healing biology. One description of Dupuytren is that it’s like the body is trying to heal a wound that isn’t there. I used to worry that any treatment described as “promoting” or “accelerating” wound healing might be exactly the wrong thing
![](https://dupuytrens.org/wp-content/uploads/2019/01/victory_1920X830-768x332.jpg)
Dupuytren: restoring balance vs. winning the war
There were a number of responses to the last blog post. Annie Stratton wrote something so insightful I’ve included it with permission at the end of this post. The last post used the analogy of war, the war on Dupuytren. That seemed reasonable for several reasons – the importance of strategy
![](https://dupuytrens.org/wp-content/uploads/2019/01/Circulation-768x332.png)
Strategies and Tactics of Dupuytren Treatment: Measurement
This is the introduction to an upcoming series of discussions on the science behind new potential preventive Dupuytren treatments. The guiding mission of the Dupuytren Research Group is to do what needs to be done to prevent and stop Dupuytren. Our goal is the conquest of Dupuytren. Dupuytren damages hands, but
![It's Time!](https://dupuytrens.org/wp-content/uploads/2019/01/Clockhand-768x332.jpg)
Happy 10th Anniversary Dupuytren Research Group!
The Dupuytren Research Group was founded ten years ago this month. Our original name was Dupuytren Foundation. Our original mission was simple: to advocate for Dupuytren patients. Providing patient education, physician education, connecting patients with patients, connecting patients with specialists, connecting surgeons with researchers, investigating alternative treatments, providing grants to researchers – these were
![](https://dupuytrens.org/wp-content/uploads/2018/12/2018Holidays1-768x332.png)
Happy Holidays from the Dupuytren Research Group
Warm holiday wishes from the very merry team at the Dupuytren Research Group!
![](https://dupuytrens.org/wp-content/uploads/2018/12/EndDupuytren.png)
Ending Dupuytren disease
What must be done to end Dupuytren disease?
![](https://dupuytrens.org/wp-content/uploads/2018/12/PrecisionFDA_685x296.png)
PrecisionFDA Dupuytren Blog
PrecisionFDA Dupuytren Blog PrecisionFDA https://precision.fda.gov/ is a US Government initiative designed to support cutting-edge genomic research and help researchers collaborate across the globe. As a member of PrecisionFDA, Dupuytren Research Group will use PrecisionFDA cloud hosting to allow authorized researchers around the world to collaborate and analyze data from the International
![](https://dupuytrens.org/wp-content/uploads/2018/11/Did-you-know.png)
Did You Know These Dupuytren Facts?
Did You Know These Dupuytren Facts? Did you know? Today, each child of a parent with Dupuytren has a one in four chance of developing Dupuytren. Did you know? Today, there’s no practical way to test if a treatment can prevent Dupuytren. Did you know? Today’s approach to Dupuytren treatment is the same as it was in the
![](https://dupuytrens.org/wp-content/uploads/2018/11/2018Black-Friday-e1677685939758.png)
Shop Amazon and Support Research: Amazon4Dup.com
The AmazonSmile program donated to charitable organizations for purchases made through Amazon.com. Sadly, Amazon reversed its course and discontinued this program in February 2023 for Dupuytren Research Group and most of the nonprofits benefiting from this program. Thanks for your prior support of Dupuytren Research through AmazonSmile! Charles Eaton MD
Recent Dupuytren Publications
- Challenges and innovations in the surgical treatment of advanced Dupuytren disease by percutaneous needle fasciotomy: indications, limitations, and medico-legal implications
- Adjuvant Treatment with Celecoxib after Collagenase Injection for Dupuytren Contracture: A Double-Blind Randomised Controlled Trial
- Biochemical and Histological Differences between Longitudinal and Vertical Fibres of Dupuytren's Palmar Aponeurosis and Innovative Clinical Implications
- Alterations in the Structure, Composition, and Organization of Galactosaminoglycan-Containing Proteoglycans and Collagen Correspond to the Progressive Stages of Dupuytren's Disease
- CASTing the net wider: A case report of PLACK syndrome associated with dilated cardiomyopathy